NSTM · OTC
It filed on time and stood behind its numbers. Of companies scoring zero, 4.0% were delisted, went bankrupt, restated or stopped filing within the following year.
Hover or tap a dot to see the filings behind that score.
NovelStem International Corp. (the “Company”) has determined that it is unable, without unreasonable effort or expense, to complete the filing of its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025 (the “1Q 2025 Form 10-Q”) within the prescribed time frame. Additional time is needed to complete the report and our auditors need additional time to complete their review of the Company’s financial statements for the quarter ended March 31, 2025. The Company expects to file the 1Q 2025 Form 10-Q within five calendar days following the prescribed filing date
NT 10-Q, filed 2025-05-15 · auditor
NovelStem International Corp. (the “Company”) has determined that it is unable, without unreasonable effort or expense, to complete the filing of its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025 (the “1Q 2025 Form 10-Q”) within the prescribed time frame. Additional time is needed to complete the report and our auditors need additional time to complete their review of the Company’s financial statements for the quarter ended March 31, 2025. The Company expects to file the 1Q 2025 Form 10-Q within five calendar days following the prescribed filing date
NovelStem International Corp. (the “Company”) has determined that it is unable, without unreasonable effort or expense, to complete the filing of its Annual Report on Form 10-K for the year ended December 31, 2024 (the “2024 Form 10-K”) within the prescribed time frame. Additional time is needed to complete the report and our auditors need additional time to complete the audit of the Company’s financial statements for the year ended December 31, 2024. The Company expects to file the 2024 Form 10-K within five calendar days following the prescribed filing date
2024-01-23auditor changed or resigned SEC →
2023-12-19auditor changed or resigned SEC →
NovelStem International Corp. (the “Company”) has determined that it is unable, without unreasonable effort or expense, to complete the filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Q3 2023 Form 10-Q”) within the prescribed time frame due to a delay in obtaining and compiling information required to be included in the Company’s Form 10-Q. Such information related to our investment in NewStem Ltd. (an Israeli entity) has been delayed by the current state of war in Israel. The Company expects to file the Q3 2023 Form 10-Q within five calendar days following the prescribed filing date
reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.
Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.
See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.Every item above is a filing this company
made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not
investment advice